In a total population of over 95,000 arthroplasty patients suffering from obesity, perioperative GLP-1 therapy was associated with fewer PJIs after THA (OR 0.74) and lower 90-day readmissions (OR 0.78). This evidence concerns the gene GLP1R and obesity disorder.